Detalles de la búsqueda
1.
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med
; 380(12): 1116-1127, 2019 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30779529
2.
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(12): 1563-1573, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284113
3.
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Lancet
; 392(10142): 123-133, 2018 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29880231
4.
Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
Ir J Med Sci
; 193(1): 45-50, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37450258
5.
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study.
Eur Urol
; 84(5): 449-454, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37500340
6.
Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399357
7.
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Lancet Gastroenterol Hepatol
; 8(11): 1015-1027, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734399
8.
Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial.
Eur Urol Oncol
; 5(2): 225-234, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34244116
9.
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma.
Eur Urol
; 82(4): 427-439, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35843776
10.
Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study.
Ther Adv Med Oncol
; 13: 17588359211042691, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34512801
11.
Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study" [Eur Urol 84(5) (2023) 449-454].
Eur Urol
; 85(2): e58-e59, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071169
12.
Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study" [Eur. Urol. (2023)].
Eur Urol
; 84(5): e123-e124, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666734
13.
Impact of zoledronic acid on renal function in patients with cancer: Clinical significance and development of a predictive model.
J Support Oncol
; 4(10): 524-9, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17136870
14.
Circulating macrophage colony stimulating factor as a marker of tumour progression.
Eur Cytokine Netw
; 13(1): 121-7, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11956031
15.
Unusual presentations of lymphoma: Case 2. Non-Hodgkin's lymphoma presenting as liver disease.
J Clin Oncol
; 20(7): 1943-6, 2002 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11919256
16.
Transesophageal Echocardiographically-Confirmed Pulmonary Vein Thrombosis in Association with Posterior Circulation Infarction.
Case Rep Neurol
; 2(1): 24-31, 2010 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-20689631
17.
Cranial nerve deficits in patients with metastatic prostate carcinoma: clinical features and treatment outcomes.
Cancer
; 101(7): 1639-43, 2004 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15468187
18.
Tumor antigens and antigen-presenting capacity in breast cancer.
Pathobiology
; 70(6): 324-32, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12865628
Resultados
1 -
18
de 18
1
Próxima >
>>